Source:http://linkedlifedata.com/resource/pubmed/id/11750170
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-12-25
|
pubmed:abstractText |
The prevalence of low-level resistance to glycopeptides (teicoplanin MIC > or = 8 microg/mL and vancomycin MIC > or = 4 microg/mL) among staphylococci was investigated over a 15 month period. A total of 2,279 isolates (1,519 S. aureus, 760 coagulase-negative staphylococcus (CNS)) were screened using inoculum of 10(6) CFU/mL and Mueller-Hinton agars supplemented with 8 microg/mL of teicoplanin. Of these, 218 isolates (136 S. aureus and 82 CNS) grew on the screening agar. For these isolates, teicoplanin and vancomycin MICs were determined by agar dilution method and a vancomycin agar screening method was evaluated. The prevalence of low-level resistance to teicoplanin and vancomycin was 7.8% and 0.1% for S. aureus and 8.8% and 0.8% for CNS, respectively. The brain heart infusion agar containing 4 microg/mL of vancomycin failed to detect two out of eight staphylococcal isolates with vancomycin MICs of 4 microg/mL. Furthermore, the method appeared to lack reproducibility. Considering the increasing incidence of vancomycin treatment failure in staphylococcal infection, a more reliable screening method is required.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0732-8893
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
155-9
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11750170-Agar,
pubmed-meshheading:11750170-Anti-Bacterial Agents,
pubmed-meshheading:11750170-Drug Resistance, Bacterial,
pubmed-meshheading:11750170-Hospitals, University,
pubmed-meshheading:11750170-Humans,
pubmed-meshheading:11750170-Microbial Sensitivity Tests,
pubmed-meshheading:11750170-Population Surveillance,
pubmed-meshheading:11750170-Staphylococcal Infections,
pubmed-meshheading:11750170-Staphylococcus,
pubmed-meshheading:11750170-Staphylococcus aureus,
pubmed-meshheading:11750170-Teicoplanin,
pubmed-meshheading:11750170-Vancomycin,
pubmed-meshheading:11750170-Vancomycin Resistance
|
pubmed:year |
2001
|
pubmed:articleTitle |
Low-level resistance to glycopeptides amongst staphylococcus species: surveillance in a university hospital and evaluation of a vancomycin screening agar.
|
pubmed:affiliation |
Department of Clinical Pathology, College of Medicine, the Catholic University of Korea, Kangnam St. Mary's Hospital, Seoul, South Korea. yjpk@cmc.cuk.ac.kr
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|